O
ISSUER//CIK 0001797336
Old Ayala, Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-K5.4 MBOld Ayala, IncMar 31, 6:38 AM ET·0001213900-23-024952
- SC 13G/A119.3 KBOld Ayala, IncFeb 8, 5:16 PM ET·0001104659-23-014617
- SC 13G94.4 KBOld Ayala, IncFeb 7, 6:01 AM ET·0001178913-23-000394
- SC 13G/A32.9 KBOld Ayala, IncFeb 6, 2:49 PM ET·0000846087-23-000077
- 8-K236.8 KBOld Ayala, IncJan 25, 4:53 PM ET·0001493152-23-002463
- SC 13G/A111.1 KBOld Ayala, IncJan 23, 4:29 PM ET·0001178913-23-000228
- 8-K201.7 KBAyala Pharmaceuticals, Inc.Jan 13, 4:01 PM ET·0001213900-23-002771
- SC 13G/A111.8 KBAyala Pharmaceuticals, Inc.Jan 9, 6:51 AM ET·0001178913-23-000101
- 8-K285.4 KBAyala Pharmaceuticals, Inc.Jan 4, 5:03 PM ET·0001193125-23-001582
- 8-K151.1 KBAyala Pharmaceuticals, Inc.Nov 23, 4:03 PM ET·0001193125-22-292007
Insiders
10- aMoon Growth Fund Limited Partnership10% Owner
- Bisker-Leib VeredDirector
- Golan RoyChief Financial Officer
- GOLDBERG MURRAY ADirector
- Gordon Gary B.Chief Medical Officer
- Harel Insurance Co LTD10% Owner
- Harel Insurance Investments & Financial Services Ltd.10% Owner
- Israel Biotech Fund I, L.P.10% Owner
- Maimon YossiCFO
- Mamluk RoniDirector, CEO
Tickers
No tickers on record
Addresses
business
1313 N. MARKET STREET SUITE 5100
WILMINGTON, DE, 19801
mailing
1313 N. MARKET STREET SUITE 5100
WILMINGTON, DE, 19801
Former Names
- Ayala Pharmaceuticals, Inc.2023-01-19